Big Pharma is a rules-based basket of 12 US-listed stocks — The top-rated US companies with the Big Pharma business model.. 45.1% backtested total return, -119.9% vs the S&P 500 since inception. Equal-weight, point-in-time, survivorship-corrected. Published for US investors. Not investment advice.
| Ticker | Company | Weight |
|---|---|---|
| AMGN | Amgen Inc. | 8.3% |
| BMY | Bristol-Myers Squibb Company | 8.3% |
| ABBV | AbbVie Inc. | 8.3% |
| INCY | Incyte Corporation | 8.3% |
| ZTS | Zoetis Inc. | 8.3% |
| MRK | Merck & Co., Inc. | 8.3% |
| GILD | Gilead Sciences, Inc. | 8.3% |
| REGN | Regeneron Pharmaceuticals, Inc. | 8.3% |
| BIIB | Biogen Inc. | 8.3% |
| NBIX | Neurocrine Biosciences, Inc. | 8.3% |
| JNJ | Johnson & Johnson | 8.3% |
| PFE | Pfizer Inc. | 8.3% |
Performance shown is backtested (hypothetical), not actual trades, benchmarked to the S&P 500 total return. Past performance does not guarantee future results. Signals is a publisher, not a broker or investment adviser. US users only.